谷歌浏览器插件
订阅小程序
在清言上使用
VIPCreated with Sketch.

Sustained Improvements over 140 Weeks in Signs, Symptoms, and Quality of Life with Upadacitinib in Adolescents and Adults with Moderate-to-severe Atopic Dermatitis: Integrated Results from the Phase 3 Measure Up 1 and Measure Up 2 Studies

Vimal H. Prajapati, Christopher G. Bunick,Kilian Eyerich,Linda Stein Gold, Fabrizio Galimberti,Brian Calimlim,Henrique Teixeira,Xiaofei Hu, Yang, Cristina Sancho,Ayman Grada,Alan D. Irvine

BRITISH JOURNAL OF DERMATOLOGY（2024）

引用 0|浏览0
暂无评分
关键词
atopic dermatitis,moderate-to-severe,patient-reported outcomes,upadacitinib
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要